Overview
Takara Bio provides kits, reagents, instruments, and services for life science research in gene discovery, regulation, function, cancer therapy, NGS, and single-cell technologies. The company offers CDMO services for regenerative medicine, including GMP manufacturing for cellular and gene therapy products at facilities in Japan, the US, Europe, China, and India. Their portfolio supports applications like CAR-T therapy, immune profiling, vaccine development, and drug discovery.
Frequently asked questions
- What manufacturing capabilities does Takara Bio offer for cell and gene therapy?
- Takara Bio provides comprehensive GMP manufacturing and quality-testing services for cellular and gene therapy products at facilities like the Center for Gene and Cell Processing in Japan and GMP stem cell facilities in Sweden.
- What geographic regions does Takara Bio serve?
- Takara Bio operates manufacturing centers in the US, Europe, China, and India, with a global sales network supporting customers inside and outside Japan, including Europe, Middle East, and Africa.
- Does Takara Bio support regulatory-compliant production?
- Yes, Takara Bio offers GMP-grade manufacturing at facilities in Japan and Sweden, along with certified service providers for NGS and single-cell technologies to advance research and development.